FARLETUZUMAB ECTERIBULIN
UNII UVG3B5TZN3

Substance Identification & Data

This profile provides standardized clinical and technical data for Farletuzumab Ecteribulin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) UVG3B5TZN3.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2407465-18-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
UVG3B5TZN3
CAS Registry Number
2407465-18-1
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
FARLETUZUMAB ECTERIBULIN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C173946
National Cancer Institute reference terminology for clinical and research data.
INN ID
11877
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
HI-185
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Farletuzumab Ecteribulin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

FARLETUZUMAB ECTERIBULIN

Common Names & Synonyms

ERIBULIN/FARLETUZUMAB ANTIBODY DRUG CONJUGATE
FARLETUZUMAB ECTERIBULIN [INN]
FARLETUZUMAB ECTERIBULIN [USAN]
FARLETUZUMAB ECTERIBULIN [WHO-DD]
IMMUNOGLOBULIN G1, ANTI-(HUMAN FOLATE RECEPTOR .ALPHA.) (HUMAN-MOUSE MONOCLONAL MORAB-003 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL MORAB-003 .KAPPA.-CHAIN, DIMER, REDUCED, THIOETHER WITH N-(3-(2-(2-(3-MERCAPTO-2,5-DIOXO-1-PYRROLIDINYL)ETHOXY)ETHOXY)-1-OXOPROPYL)-L-VALYL-N5-(AMINOCARBONYL)-N-(4-((((((2S)-3-((2R,3R,3AS,7R,8AS,9S,10AR,11S,12R,13AR,13BS,15S,18S,21S,24S,26R,28R,29AS)-OCTACOSAHYDRO-3-METHOXY-26-METHYL-20,27-BIS(METHYLENE)-5-OXO-11,15:18,21:24,28-TRIEPOXY-7,9-ETHANO-12,15-METHANO-9H,15H-FURO(3,2-I)FURO(2',3':5,6)PYRANO(4,3-B)(1,4)DIOXACYCLOPENTACOSIN-2-YL)-2-HYDROXYPROPYL)AMINO)CARBONYL)OXY)METHYL)PHENYL)-L-ORNITHINAMIDE

Technical Codes

MORAB-202

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus